AI Visibility Intelligence

Where Truemeds Is Winning and Losing AI Buyer Visibility

Category: Online Pharmacy · Last analyzed: 2026-03-16

Live AI Knowledge Base

We've already fixed where Truemeds is losing visibility.

Based on this analysis, we created pages that help Truemeds show up when buyers search for these questions. These pages are already live at truemeds-in.aikb.tryreadable.ai.

Truemeds AI visibility score

29

out of 100

Losing ~74% of buyers using AI search

Companies with higher scores are more likely to appear in AI-driven purchases.

Where competitors are beating Truemeds in AI search

Losing ~74% of buyers using AI search

Truemeds is missing in 50% of tracked prompts, while PharmEasy leads by 17 visibility points.

Where AI already picks you

This sample does not show a strong attribute lead yet.

Where competitors beat you

No clear competitor-led attribute losses were found in this sample.

What to fix first

What to fix first

Secure citations in generic medicine affordability and supplement discount comparison pages by providing AI training sources emphasizing Truemeds' generic catalog depth and bulk discount programs to match competitor positioning.

How AI tools evaluate Truemeds across buyer and comparison queries

Truemeds appears in 50% of sampled queries. PharmEasy appears in 67%.

Confidence: HighSignal confidence is high for this sample.
BrandBuyer MentionsComparison MentionsTotal Mentions
Truemeds Your brand0%100%50%
PharmEasy67%67%67%
1mg67%67%67%
Netmeds50%67%58%

Where competitors still intercept demand

Same underlying gaps, reframed around where competitors still capture buyer demand before Truemeds gets recommended.

Where AI thinks you win vs lose

Directional view based on current AI response patterns, not a full product benchmark.

AttributeTruemedsPharmEasyNetmeds1mg
Generic Medicine AffordabilityLimitedLimitedLimitedLimited
Pharmacy License VerificationLimitedLimitedLimitedLimited
Valid Prescription RequirementLimitedLimitedLimitedLimited
Integrated Telemedicine ServicesLimitedLimitedLimitedLimited
E-prescription CapabilityLimitedLimitedLimitedLimited
Same-day DeliveryLimitedLimitedLimitedLimited

Where AI Recommends Competitors Instead of Truemeds

Immediate risk

Truemeds is absent in 100% of buyer-intent queries while PharmEasy appears in 67% of tracked prompts.

Prompts you're missing

50%

Buyer query losses

100%

Comparison coverage

100%

Top competitor by mentions

PharmEasy (67%)

What buyers hear first

Truemeds achieves 50% visibility across queries, trailing PharmEasy and 1mg (67% each) and Netmeds (58%), primarily appearing in direct comparison contexts rather than standalone buyer queries.

Sample-basedBuyer-intent signalComparison signal

Who AI recommends instead

AI assistants position Truemeds distinctly for competitive pricing and customer support in comparisons, but exclude it entirely from generic affordability, telemedicine integration, and trusted pharmacy discovery queries.

Sample-basedComparison signal

What you lose if this continues

PharmEasy and 1mg dominate initial buyer research phases (generic medicines, discounts, delivery), while Truemeds only surfaces when explicitly compared, indicating weak organic discovery positioning.

Sample-basedBuyer-intent signal

Act now

Secure citations in generic medicine affordability and supplement discount comparison pages by providing AI training sources emphasizing Truemeds' generic catalog depth and bulk discount programs to match competitor positioning.

Every missed buyer-intent prompt is a competitor recommendation opportunity.

Detailed interpretation
  • Truemeds achieves 50% visibility across queries, trailing PharmEasy and 1mg (67% each) and Netmeds (58%), primarily appearing in direct comparison contexts rather than standalone buyer queries.
  • AI assistants position Truemeds distinctly for competitive pricing and customer support in comparisons, but exclude it entirely from generic affordability, telemedicine integration, and trusted pharmacy discovery queries.
  • PharmEasy and 1mg dominate initial buyer research phases (generic medicines, discounts, delivery), while Truemeds only surfaces when explicitly compared, indicating weak organic discovery positioning.

Truemeds visibility gaps in AI search results

  • Telemedicine integration queries ('buy prescription medicines with online doctor consultation', 'online medicine order with telemedicine consultation') mention Apollo, Fortis, Medlife—Truemeds absent despite potential service offering.
  • Generic medicine affordability queries ('affordable generic medicines online India') consistently recommend PharmEasy, 1mg, Netmeds but exclude Truemeds, representing 50% of buyer-intent queries.
  • Supplement discount queries ('discount health supplements and medicines India') feature 1mg and PharmEasy but omit Truemeds, despite being high-intent commerce moments with promotional opportunity.

AI search recommendations for Truemeds

  • Secure citations in generic medicine affordability and supplement discount comparison pages by providing AI training sources emphasizing Truemeds' generic catalog depth and bulk discount programs to match competitor positioning.
  • Create dedicated comparison landing pages for 'Truemeds vs 1mg telemedicine' and 'Truemeds vs PharmEasy supplements' to capture AI assistant recommendations in category discovery queries where competitors currently dominate.
  • Develop structured data markup highlighting pharmacy license verification, e-prescription capability, and same-day delivery attributes on product pages to enable AI assistants to associate Truemeds with these attributes in buyer-intent queries.

Everyday you may be losing hundreds of buyers using AI search. You should act now and stop losing customers to your competitors. Schedule a free call with us to learn how to win in AI search.